Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Capella Therapeutics

Capella Therapeutics?uq=BoBgMMEs
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of small molecule drugs created to treat cancer and inflammatory diseases. The company's epidermal growth factor receptor inhibitor accumulates in the brain and can cross the blood-brain barrier and kill the non-small cell lung cancer in the brain, enabling physicians to address previously untreatable types of lung cancer.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Primary Office
  • 7909 Silverton Avenue
  • Suite 209
  • San Diego, CA 92126
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Capella Therapeutics’s full profile, request a free trial.

Capella Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 02-Feb-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Capella Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JLABS Accelerator/Incubator 000 0000 000000 0

Capella Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Yun Long Ph.D Founder, Chief Executive Officer & Chairman of the Board

Capella Therapeutics Board Members (2)

Name Representing Role Since Contact
Info
Alan Lewis Ph.D Self Board Member 000 0000
Yun Long Ph.D Capella Therapeutics Founder, Chief Executive Officer & Chairman of the Board 000 0000